1
|
Myat A, Redwood SR, Qureshi AC, Spertus JA
and Williams B: Resistant hypertension. BMJ.
345(e7473)2012.PubMed/NCBI View Article : Google Scholar
|
2
|
Vilela-Martin JF, Giollo-Junior LT,
Chiappa GR, Cipriano-Junior G, Vieira PJ, dos Santos Ricardi F,
Paz-Landim MI, de Andrade DO, Cestário Edo E, Cosenso-Martin LN, et
al: Effects of transcutaneous electrical nerve stimulation (TENS)
on arterial stiffness and blood pressure in resistant hypertensive
individuals: Study protocol for a randomized controlled trial.
Trials. 17(168)2016.PubMed/NCBI View Article : Google Scholar
|
3
|
Rimoldi SF, Messerli FH, Bangalore S and
Scherrer U: Resistant hypertension: What the cardiologist needs to
know. Eur Heart J. 36:2686–2695. 2015.PubMed/NCBI View Article : Google Scholar
|
4
|
Williams B, Mancia G, Spiering W, Agabiti
Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G,
Dominiczak A, et al: 2018 ESC/ESH Guidelines for the management of
arterial hypertension. Eur Heart J. 39:3021–3104. 2019.PubMed/NCBI View Article : Google Scholar
|
5
|
Achelrod D, Wenzel U and Frey S:
Systematic review and meta-analysis of the prevalence of resistant
hypertension in treated hypertensive populations. Am J Hypertens.
28:355–361. 2015.PubMed/NCBI View Article : Google Scholar
|
6
|
Krieger EM, Drager LF, Giorgi DMA, Pereira
AC, Barreto-Filho JAS, Nogueira AR, Mill JG, Lotufo PA, Amodeo C,
Batista MC, et al: Spironolactone versus clonidine as a fourth-drug
therapy for resistant hypertension: The ReHOT randomized Study
(Resistant Hypertension Optimal Treatment). Hypertension.
71:681–690. 2018.PubMed/NCBI View Article : Google Scholar
|
7
|
Whelton PK, Carey RM, Aronow WS, Casey DE
Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S,
Jamerson KA, Jones DW, et al: 2017
ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the
prevention, detection, evaluation, and management of high blood
pressure in adults: A Report of the American College of
Cardiology/American Heart Association Task Force on Clinical
Practice Guidelines. J Am Coll Cardiol. 71:e127–e248.
2018.PubMed/NCBI View Article : Google Scholar
|
8
|
de Jager RL and Blankestijn PJ:
Pathophysiology I: The kidney and the sympathetic nervous system.
Eurointervention. 9:R42–R47. 2013.PubMed/NCBI View Article : Google Scholar
|
9
|
Fan H, Tian ZX, Ma SM, Yang NN and Liu CZ:
Research progress of mechanism of oxidase stress-endoplasmic
reticulum stress-autophagy of acupuncture in rostral ventrolateral
medulla of hypertension. CJTCMP. 36:4128–4131. 2021.
|
10
|
Cicconetti P, Di Berardino A, Tortorelli
D'Ambrosio M and Cacciafesta M: Resistant hypertension in the
elderly. Recenti Prog Med. 108:316–323. 2017.PubMed/NCBI View Article : Google Scholar : (In Italian).
|
11
|
Hering D, Mahfoud F, Walton AS, Krum H,
Lambert GW, Lambert EA, Sobotka PA, Böhm M, Cremers B, Esler MD and
Schlaich MP: Renal denervation in moderate to severe CKD. J Am Soc
Nephrol. 23:1250–1257. 2012.PubMed/NCBI View Article : Google Scholar
|
12
|
Laurent S, Schlaich M and Esler M: New
drugs, procedures, and devices for hypertension. Lancet.
380:591–600. 2012.PubMed/NCBI View Article : Google Scholar
|
13
|
Li HB, Lu Y and Zheng TZ: Rostral
ventrolateral medulla and primary hypertension. Chin J Hypertens.
19:917–919. 2011.
|
14
|
Victor RG: Carotid baroreflex activation
therapy for resistant hypertension. Nat Rev Cardiol. 12:451–463.
2015.PubMed/NCBI View Article : Google Scholar
|
15
|
Zar T and Peixoto AJ: Paroxysmal
hypertension due to baroreflex failure. Kidney Int. 74:126–131.
2008.PubMed/NCBI View Article : Google Scholar
|
16
|
Doucet BM, Lam A and Griffin L:
Neuromuscular electrical stimulation for skeletal muscle function.
Yale J Biol Med. 85:201–215. 2012.PubMed/NCBI
|
17
|
Peng WW, Tang ZY, Zhang FR, Li H, Kong YZ,
Iannetti GD and Hu L: Neurobiological mechanisms of TENS-induced
analgesia. Neuroimage. 195:396–408. 2019.PubMed/NCBI View Article : Google Scholar
|
18
|
Johnson MI, Paley CA, Jones G, Mulvey MR
and Wittkopf PG: Efficacy and safety of transcutaneous electrical
nerve stimulation (TENS) for acute and chronic pain in adults: A
systematic review and meta-analysis of 381 studies (the meta-TENS
study). BMJ Open. 12(e051073)2022.PubMed/NCBI View Article : Google Scholar
|
19
|
Alahmari KA, Silvian P, Ahmad I, Reddy RS,
Tedla JS, Kakaraparthi VN and Rengaramanujam K: Effectiveness of
low-frequency stimulation in proprioceptive neuromuscular
facilitation techniques for post ankle sprain balance and
proprioception in adults: A randomized controlled trial. Biomed Res
Int. 2020(9012930)2020.PubMed/NCBI View Article : Google Scholar
|
20
|
Hering D, Trzebski A and Narkiewicz K:
Recent advances in the pathophysiology of arterial hypertension:
Potential implications for clinical practice. Pol Arch Intern Med.
127:195–204. 2017.PubMed/NCBI View Article : Google Scholar
|
21
|
Ott C, Janka R, Schmid A, Titze S, Ditting
T, Sobotka PA, Veelken R, Uder M and Schmieder RE: Vascular and
renal hemodynamic changes after renal denervation. Clin J Am Soc
Nephrol. 8:1195–1201. 2013.PubMed/NCBI View Article : Google Scholar
|
22
|
Esler MD, Böhm M, Sievert H, Rump CL,
Schmieder RE, Krum H, Mahfoud F and Schlaich MP: Catheter-based
renal denervation for treatment of patients with
treatment-resistant hypertension: 36 month results from the
SYMPLICITY HTN-2 randomized clinical trial. Eur Heart J.
35:1752–1759. 2014.PubMed/NCBI View Article : Google Scholar
|
23
|
Esler MD, Krum H, Schlaich M, Schmieder
RE, Böhm M and Sobotka PA: Renal sympathetic denervation for
treatment of drug-resistant hypertension: One-year results from the
Symplicity HTN-2 randomized, controlled trial. Circulation.
126:2976–2982. 2012.PubMed/NCBI View Article : Google Scholar
|
24
|
Esler MD, Krum H, Sobotka PA, Schlaich MP,
Schmieder RE and Böhm M: Renal sympathetic denervation in patients
with treatment-resistant hypertension (The Symplicity HTN-2 Trial):
A randomised controlled trial. Lancet. 376:1903–1909.
2010.PubMed/NCBI View Article : Google Scholar
|
25
|
Kandzari DE, Böhm M, Mahfoud F, Townsend
RR, Weber MA, Pocock S, Tsioufis K, Tousoulis D, Choi JW, East C,
et al: Effect of renal denervation on blood pressure in the
presence of antihypertensive drugs: 6-month efficacy and safety
results from the SPYRAL HTN-ON MED proof-of-concept randomised
trial. Lancet. 391:2346–2355. 2018.PubMed/NCBI View Article : Google Scholar
|
26
|
Townsend RR, Mahfoud F, Kandzari DE, Kario
K, Pocock S, Weber MA, Ewen S, Tsioufis K, Tousoulis D, Sharp ASP,
et al: Catheter-based renal denervation in patients with
uncontrolled hypertension in the absence of antihypertensive
medications (SPYRAL HTN-OFF MED): A randomised, sham-controlled,
proof-of-concept trial. Lancet. 390:2160–2170. 2017.PubMed/NCBI View Article : Google Scholar
|
27
|
Yang XX and Zhao D: Study on the
antihypertensive effect of renal denervation. Chin J Hypertens.
29:1190–1195. 2021.
|
28
|
Azizi M, Schmieder RE, Mahfoud F, Weber
MA, Daemen J, Davies J, Basile J, Kirtane AJ, Wang Y, Lobo MD, et
al: Endovascular ultrasound renal denervation to treat hypertension
(RADIANCE-HTN SOLO): A multicentre, international, single-blind,
randomised, sham-controlled trial. Lancet. 391:2335–2345.
2018.PubMed/NCBI View Article : Google Scholar
|
29
|
Chen S, Kiuchi MG, Schmidt B, Hoye NA,
Acou WJ, Liu S, Chun KRJ and Pürerfellner H: Renal denervation for
mild-moderate treatment-resistant hypertension : A timely
intervention? Herz. 44:412–418. 2019.PubMed/NCBI View Article : Google Scholar
|
30
|
Wang L, Lu CZ, Zhang X, Zhang F, Xia DS,
Chen X, Zhao XD, Guo SZ, Yu X and Jian L: Efficacy of renal
sympathetic denervation in resistent hypertension with high renin
levels. Chin J Hypertens. 22:1084–1086. 2014.
|
31
|
Mahfoud F, Bakris G, Bhatt DL, Esler M,
Ewen S, Fahy M, Kandzari D, Kario K, Mancia G, Weber M, et al:
Reduced blood pressure-lowering effect of catheter-based renal
denervation in patients with isolated systolic hypertension: Data
from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry. Eur Heart
J. 38:93–100. 2017.PubMed/NCBI View Article : Google Scholar
|
32
|
Lohmeier TE, Irwin ED, Rossing MA, Serdar
DJ and Kieval RS: Prolonged activation of the baroreflex produces
sustained hypotension. Hypertension. 43:306–311. 2004.PubMed/NCBI View Article : Google Scholar
|
33
|
Bisognano JD, Bakris G, Nadim MK, Sanchez
L, Kroon AA, Schafer J, de Leeuw PW and Sica DA: Baroreflex
activation therapy lowers blood pressure in patients with resistant
hypertension: Results from the double-blind, randomized,
placebo-controlled rheos pivotal trial. J Am Coll Cardiol.
58:765–773. 2011.PubMed/NCBI View Article : Google Scholar
|
34
|
Campón-Checkroun AM, Luceño-Mardones A,
Riquelme I, Oliva-Pascual-Vaca J, Ricard F and Oliva-Pascual-Vaca
Á: Effects of the right carotid sinus compression technique on
blood pressure and heart rate in medicated patients with
hypertension. J Altern Complement Med. 24:1108–1112.
2018.PubMed/NCBI View Article : Google Scholar
|
35
|
de Leeuw PW, Alnima T, Lovett E, Sica D,
Bisognano J, Haller H and Kroon AA: Bilateral or unilateral
stimulation for baroreflex activation therapy. Hypertension.
65:187–192. 2015.PubMed/NCBI View Article : Google Scholar
|
36
|
Hoppe UC, Brandt MC, Wachter R, Beige J,
Rump LC, Kroon AA, Cates AW, Lovett EG and Haller H: Minimally
invasive system for baroreflex activation therapy chronically
lowers blood pressure with pacemaker-like safety profile: Results
from the Barostim neo trial. J Am Soc Hypertens. 6:270–276.
2012.PubMed/NCBI View Article : Google Scholar
|
37
|
Bakris GL, Nadim MK, Haller H, Lovett EG,
Schafer JE and Bisognano JD: Baroreflex activation therapy provides
durable benefit in patients with resistant hypertension: Results of
long-term follow-up in the Rheos Pivotal Trial. J Am Soc Hypertens.
6:152–158. 2012.PubMed/NCBI View Article : Google Scholar
|
38
|
Chang Lee SN, Ho TJ, Shibu MA, Day CH,
Viswanadha VP, Lai CH, Chen YL, Hsieh DJ, Chen YS and Huang CY:
Protective effects of electroacupuncture at LR3 on cardiac
hypertrophy and apoptosis in hypertensive rats. Acupunct Med.
34:201–208. 2016.PubMed/NCBI View Article : Google Scholar
|
39
|
Guo ZL, Fu LW, Su HF, Tjen ALSC and
Longhurst JC: Role of TRPV1 in acupuncture modulation of reflex
excitatory cardiovascular responses. Am J Physiol Regul Integr Comp
Physiol. 314:R655–R66. 2018.PubMed/NCBI View Article : Google Scholar
|
40
|
Li P, Tjen-A-Looi SC, Cheng L, Liu D,
Painovich J, Vinjamury S and Longhurst JC: Long-lasting reduction
of blood pressure by electroacupuncture in patients with
hypertension: Randomized controlled trial. Med Acupunct.
27:253–266. 2015.PubMed/NCBI View Article : Google Scholar
|
41
|
Tjen ALSC, Guo ZL, Fu LW and Longhurst JC:
Paraventricular nucleus modulates excitatory cardiovascular
reflexes during Electroacupuncture. Sci Rep.
6(25910)2016.PubMed/NCBI View Article : Google Scholar
|
42
|
Tjen ALSC, Li P and Longhurst JC:
Prolonged inhibition of rostral ventral lateral medullary premotor
sympathetic neurons by electroacupuncture in cats. Auton Neurosci.
106:119–1131. 2003.PubMed/NCBI View Article : Google Scholar
|
43
|
Liu Y, Park JE, Shin KM, Lee M, Jung HJ,
Kim AR, Jung SY, Yoo HR, Sang KO and Choi SM: Acupuncture lowers
blood pressure in mild hypertension patients: A randomized,
controlled, assessor-blinded pilot trial. Complement Ther Med.
23:658–665. 2015.PubMed/NCBI View Article : Google Scholar
|
44
|
Feldstein CA: Lowering blood pressure to
prevent stroke recurrence: A systematic review of long-term
randomized trials. J Am Soc Hypertens. 8:503–513. 2014.PubMed/NCBI View Article : Google Scholar
|
45
|
Yang J, Chen J, Yang M, Yu S, Ying L, Liu
GJ, Ren YL, Wright JM and Liang FR: Acupuncture for hypertension.
Cochrane Database Syst Rev. 11(CD008821)2018.PubMed/NCBI View Article : Google Scholar
|
46
|
Tan X, Pan Y, Su W, Gong S, Zhu H, Chen H
and Lu S: Acupuncture therapy for essential hypertension: A network
meta-analysis. Ann Transl Med. 7(266)2019.PubMed/NCBI View Article : Google Scholar
|
47
|
Wang Y, Shi GX, Tian ZX, Liu JH, Qi YS, Tu
JF, Yang JW, Wang LQ and Liu CZ: Transcutaneous electrical acupoint
stimulation for high-normal blood pressure: Study protocol for a
randomized controlled pilot trial. Trials. 22(140)2021.PubMed/NCBI View Article : Google Scholar
|
48
|
Stein C, Dal Lago P, Ferreira JB, Casali
KR and Plentz RD: Transcutaneous electrical nerve stimulation at
different frequencies on heart rate variability in healthy
subjects. Auton Neurosci. 165:205–208. 2011.PubMed/NCBI View Article : Google Scholar
|
49
|
Jacobsson F, Himmelmann A, Bergbrant A,
Svensson A and Mannheimer C: The effect of transcutaneous electric
nerve stimulation in patients with therapy-resistant hypertension.
J Hum Hypertens. 14:795–798. 2000.PubMed/NCBI View Article : Google Scholar
|
50
|
Silverdal J, Mourtzinis G, Stener-Victorin
E, Mannheimer C and Manhem K: Antihypertensive effect of
low-frequency transcutaneous electrical nerve stimulation (TENS) in
comparison with drug treatment. Blood Press. 21:306–310.
2012.PubMed/NCBI View Article : Google Scholar
|
51
|
Do Amaral Sartori S, Stein C, Coronel CC,
Macagnan FE and Plentz RDM: Effects of transcutaneous electrical
nerve stimulation in autonomic nervous system of hypertensive
patients: A randomized controlled trial. Curr Hypertens Rev.
14:66–71. 2018.PubMed/NCBI View Article : Google Scholar
|
52
|
Vilela-Martin JF, Giollo-Junior LT,
Chiappa GR, Cipriano-Junior G, Vieira PJ, dos Santos Ricardi F,
Paz-Landim MI, de Andrade DO, Cestário Edo E, Cosenso-Martin LN, et
al: Effects of transcutaneous electrical nerve stimulation (TENS)
on arterial stiffness and blood pressure in resistant hypertensive
individuals: Study protocol for a randomized controlled trial.
Trials. 17(168)2016.PubMed/NCBI View Article : Google Scholar
|
53
|
Chen L, Shen Y, Liu S and Cao Y:
Transcutaneous electrical acupoint stimulation improved
preoperative blood pressure in gynecological malignant tumor
patients with hypertension: A randomized, controlled trial. Front
Oncol. 12(906528)2022.PubMed/NCBI View Article : Google Scholar
|
54
|
Mills KT, Stefanescu A and He J: The
global epidemiology of hypertension. Nat Rev Nephrol. 16:223–237.
2020.PubMed/NCBI View Article : Google Scholar
|
55
|
Lee JH, Kim KI and Cho MC: Current status
and therapeutic considerations of hypertension in the elderly.
Korean J Intern Med. 34:687–695. 2019.PubMed/NCBI View Article : Google Scholar
|
56
|
Flynn JT: Hypertension in the young:
Epidemiology, sequelae and therapy. Nephrol Dial Transplant.
24:370–375. 2009.PubMed/NCBI View Article : Google Scholar
|